Insider · CIK 0001331843
Mark Sullivan
Files at DFTX (Definium Therapeutics, Inc.). First filing Dec 27, 2024, latest Sep 29, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DFTX: Definium Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Definium Therapeutics, Inc. | $514k 14,051 shares | -3% | - | |
| 22Weak | Definium Therapeutics, Inc. | $198k 10,702 shares | -4% | +278% from low-3% from high | |
| 21Weak | Definium Therapeutics, Inc. | $148k 11,276 shares | -4% | +167% from low-8% from high | |
| 20Weak | Definium Therapeutics, Inc. | $110k 11,278 shares | -4% | +100% from low-4% from high | |
| 19Weak | Definium Therapeutics, Inc. | $78k 11,491 shares | -4% | +40% from low-31% from high | |
| 16Weak | Definium Therapeutics, Inc. | $34k 4,519 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -14,051 | $36.57 | $514k | 494,228 | 13 d ago |
| Sep 14, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +125,000 | $0.00 | $0 | 508,279 | 28 d ago |
| Mar 25, 2026 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -10,702 | $18.47 | $198k | 271,079 | Mar 26, 2026 |
| Feb 3, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +125,000 | $0.00 | $0 | 407,576 | Feb 5, 2026 |
| Dec 26, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -11,276 | $13.15 | $148k | 282,576 | Dec 29, 2025 |
| Sep 25, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -11,278 | $9.77 | $110k | 293,852 | Sep 26, 2025 |
| Jun 25, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -11,491 | $6.80 | $78k | 305,130 | Jun 26, 2025 |
| Dec 26, 2024 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -4,519 | $7.43 | $34k | 173,197 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.